Skip to main content

Table 1 Demographic and clinical characteristics of study participants (n = 100)

From: Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia

CharacteristicsNumberProportion
Age group
  < 1455%
 15–242929%
 25–343535%
 35–441717%
 45–5466%
 55–6444%
  > 6422%
 Missed22%
 Total100100%
Sex
 Male5555%
 Female4545%
 Total100100%
Treatment history
 New5055.6%
 Relapse2932.2%
 Failure77.8%
 A loss to follow up44.4%
 Total90100.0%
Specimen type
 Sputum6262.0%
 Extrapulmonary3838.0%
 Total100100.0%
Extrapulmonary samples
 Lymph node1950.0%
 Pleural fluid513.2%
 Pus410.5%
 Abscess410.5%
 Ascetic fluid38.0%
 Unspecified body fluid25.2%
 BAL12.6%
 Total38100.0%